Skip to main content
OpenTrials
Completed

NCT Number: NCT05444777

The Effect of Low Dose Ketamine on Narcotic Consumption in Patients Undergoing Laparoscopic Cholecystectomy

This double-blinded randomized control trial aims to analyze the effect of low dose Ketamine on narcotic consumption, in patients undergoing Laparoscopic cholecystectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all ASA 1 and 2 patients undergoing Laparoscopic Cholecystectomy electively.

Exclusion criteria

  • Hepatic and renal disease and ASA 3 and 4 patients.

Treatment and study plan

Ketamine Hydrochloride

Drug

Ketamine was given prior to wound closure.

Other names: ketasol

Primary outcomes

  1. pain score using Visual Analogue scale, ranging from 0 (minimum) and 10 (maximum), 3 and below showing no pain and scores above 3 showing moderate to severe pain.

    Time frame: Baseline on arrival in the post anaesthesia care unit and then every fifteen minutes unto one hour

    Change in pain score using Visual Analogue Scale

Secondary outcomes

  1. narcotic consumption in the post operative anaesthesia care unit

    Time frame: postoperatively, after arrival in the post anaesthesia care unit at every fifteen minutes unto one hour

    requirement of narcotic in the post anaesthesia care unit

Sponsors and collaborators

Lead sponsor

Aga Khan University

Other

Registry information

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Jul 6, 2022
Registry last updated
Jul 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.